InvestorsHub Logo
Followers 1
Posts 235
Boards Moderated 0
Alias Born 10/03/2014

Re: Polyphemus post# 30

Saturday, 10/19/2019 8:34:45 AM

Saturday, October 19, 2019 8:34:45 AM

Post# of 1032
ECOR has clearly been run like a pharmaceutical company. Large upfront investment to eventually get to a point of great acceptance and growth. The foundation that has been laid is very powerful. There is little doubt of future success. I expect to see a breakout in sales starting about July 2020. Some innovative techniques are needed to bridge the gap until then. I believe this can be done with the new CEO and a few well placed consultant/advisors with device experience.

If I am correct, ECOR will be in great position as it sales curve will look more a pharmaceutical company. It will have by then blended the great strategic thinking of pharma and combined it with the innovation and quick moving techniques that I hope the new CEO will bring.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ECOR News